TIL
$16.86
Instil Bio
$.44
2.68%
TIL
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.20)
Revenue:  N/A
Thursday
Aug 12
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when TIL reports earnings?
Beat
Meet
Miss

Where is TIL's stock price going from here?
Up
Flat
Down
Stock chart of TIL
Analysts
Summary of analysts' recommendations for TIL
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Instil Bio Inc. is a clinical-stage biopharmaceutical company. It is focused on developing an innovative cell therapy pipeline of autologous TIL therapies for the treatment of patients with cancer. Instil Bio Inc. is based in DALLAS.